These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30012766)

  • 1. Significantly Improved Pharmacokinetics Enhances
    Zhao Y; Lee MH; Paderu P; Lee A; Jimenez-Ortigosa C; Park S; Mansbach RS; Shaw KJ; Perlin DS
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012766
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Zhao M; Lepak AJ; VanScoy B; Bader JC; Marchillo K; Vanhecker J; Ambrose PG; Andes DR
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378706
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Hager CL; Larkin EL; Long L; Zohra Abidi F; Shaw KJ; Ghannoum MA
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311065
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacodynamics of a Long-Acting Echinocandin, CD101, in a Neutropenic Invasive-Candidiasis Murine Model Using an Extended-Interval Dosing Design.
    Lepak AJ; Zhao M; VanScoy B; Ambrose PG; Andes DR
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APX001 Is Effective in the Treatment of Murine Invasive Pulmonary Aspergillosis.
    Gebremariam T; Alkhazraji S; Alqarihi A; Jeon HH; Gu Y; Kapoor M; Shaw KJ; Ibrahim AS
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata.
    Bader JC; Lakota EA; Flanagan S; Ong V; Sandison T; Rubino CM; Bhavnani SM; Ambrose PG
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis.
    Wiederhold NP; Najvar LK; Shaw KJ; Jaramillo R; Patterson H; Olivo M; Catano G; Patterson TF
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral glucan synthase inhibitor SCY-078 is effective in an experimental murine model of invasive candidiasis caused by WT and echinocandin-resistant Candida glabrata.
    Wiederhold NP; Najvar LK; Jaramillo R; Olivo M; Pizzini J; Catano G; Patterson TF
    J Antimicrob Chemother; 2018 Feb; 73(2):448-451. PubMed ID: 29177447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Potential of Fosmanogepix (APX001) for Intra-abdominal Candidiasis: from Lesion Penetration to Efficacy in a Mouse Model.
    Lee A; Wang N; Carter CL; Zimmerman M; Dartois V; Shaw KJ; Perlin DS; Zhao Y
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against echinocandin-resistant Candida glabrata.
    Wiederhold NP; Najvar LK; Fothergill AW; Bocanegra R; Olivo M; McCarthy DI; Fukuda Y; Mitsuyama J; Patterson TF
    J Antimicrob Chemother; 2016 Mar; 71(3):692-5. PubMed ID: 26620102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspofungin dose escalation for invasive candidiasis due to resistant Candida albicans.
    Wiederhold NP; Najvar LK; Bocanegra RA; Kirkpatrick WR; Patterson TF
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3254-60. PubMed ID: 21502632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic Properties of Micafungin in Critically Ill Patients Diagnosed with Invasive Candidiasis.
    Boonstra JM; van der Elst KC; Veringa A; Jongedijk EM; Brüggemann RJ; Koster RA; Kampinga GA; Kosterink JG; van der Werf TS; Zijlstra JG; Touw DJ; Alffenaar JWC
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD101: a novel long-acting echinocandin.
    Zhao Y; Perez WB; Jiménez-Ortigosa C; Hough G; Locke JB; Ong V; Bartizal K; Perlin DS
    Cell Microbiol; 2016 Sep; 18(9):1308-16. PubMed ID: 27354115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region.
    Wang H; Xu YC; Hsueh PR
    Future Microbiol; 2016 Oct; 11():1461-1477. PubMed ID: 27750452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical perspectives on echinocandin resistance among Candida species.
    Shields RK; Nguyen MH; Clancy CJ
    Curr Opin Infect Dis; 2015 Dec; 28(6):514-22. PubMed ID: 26524326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic target evaluation of a novel oral glucan synthase inhibitor, SCY-078 (MK-3118), using an in vivo murine invasive candidiasis model.
    Lepak AJ; Marchillo K; Andes DR
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1265-72. PubMed ID: 25512406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abdominal candidiasis is a hidden reservoir of echinocandin resistance.
    Shields RK; Nguyen MH; Press EG; Clancy CJ
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7601-5. PubMed ID: 25288081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Activity Relationships of a Series of Echinocandins and the Discovery of CD101, a Highly Stable and Soluble Echinocandin with Distinctive Pharmacokinetic Properties.
    James KD; Laudeman CP; Malkar NB; Krishnan R; Polowy K
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27919891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel arylamidine T-2307 maintains in vitro and in vivo activity against echinocandin-resistant Candida albicans.
    Wiederhold NP; Najvar LK; Fothergill AW; Bocanegra R; Olivo M; McCarthy DI; Kirkpatrick WR; Fukuda Y; Mitsuyama J; Patterson TF
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1341-3. PubMed ID: 25451054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.